P r o m o S M

Very interesting ideas. You are talking about two issues, face-face and technology, wish result in two other issues among them. Face-face interaction between sponsors and research sites team member and face-face among research sites teams and study research participants. The other issue is using technology again with two different groups research sites and research study participants. How are you going to assess those issues to identify which one is the best for all stake holders/people involved in clinical research?